Stocktoria

uniQure N.V. QURE

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-02-05 · LEI

uniQure N.V. financials (annual)

Revenue
$25.1M $13.1M $11.3M $7.3M $37.5M $524.0M $106.5M $15.8M $27.1M $16.1M 2016201720182019202020212022202320242025
Net income
-$308.5M -$239.6M -$199.0M 2016201720182019202020212022202320242025
Free cash flow
-$87.5M -$68.7M -$78.4M -$104.3M -$142.1M $270.5M -$162.7M -$153.1M -$186.1M -$178.4M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$16.1M$27.1M$15.8M$106.5M$524.0M$37.5M$7.3M$11.3M$13.1M$25.1M
R&D expense$140.7M$143.8M$214.9M$197.6M$143.5M$122.4M$94.7M$74.8M$72.2M$72.5M
SG&A expense$65.5M$52.7M$74.6M$55.1M$56.3M$42.6M$33.5M$25.3M$24.6M$26.0M
Operating income-$185.3M-$184.3M-$282.9M-$143.2M$310.6M-$125.4M-$121.1M-$88.2M-$71.3M-$71.9M
Interest expense$41.6M$11.7M$7.5M$3.8M$3.8M$2.2M$2.2M$2.2M
Income tax$5.6M$2.4M$1.9M-$1.5M$3.2M-$16.4M$231,000-$199,000$1.1M
Net income-$199.0M-$239.6M-$308.5M
EPS (diluted)$-3.46$-4.92$-6.47$-2.71$7.04$-2.81$-3.11
Operating cash flow-$178.0M-$182.7M-$145.9M-$145.1M$288.0M-$134.8M-$98.7M-$76.0M-$64.3M-$72.2M
Free cash flow-$178.4M-$186.1M-$153.1M-$162.7M$270.5M-$142.1M-$104.3M-$78.4M-$68.7M-$87.5M
Cash & equivalents$80.2M$158.9M$241.4M$228.0M$556.3M$244.9M$377.8M$234.9M$159.4M$132.5M
Inventory$12.0M$6.9M
Total assets$824.9M$556.5M$831.7M$705.0M$809.2M$340.4M$448.6M$273.9M$209.6M$190.3M
Total liabilities$626.0M$563.3M$624.0M$229.0M$213.4M$96.5M$125.6M$94.3M$120.3M$126.6M
Shareholders' equity$198.9M-$6.8M$207.7M$476.0M$595.8M$243.9M$323.1M$179.6M$89.4M$63.6M

Growth · year-over-year · Revenue CAGR -4.8%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-40.6%+71.2%-85.1%-79.7%+1296.8%+415.2%-35.5%-13.9%-47.8%+137.3%
EPS growth-138.5%
Free cash flow growth-160.2%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.